PT-141 NASAL SPRAY 10MG: 100MCG PER SPRAY

Description

Legal Disclaimer
This information has not been reviewed or endorsed by the US FDA. It is provided solely for educational and research purposes. PT-141 (Bremelanotide) is not approved for medical use, human consumption, or as a therapeutic treatment in this context.

Product Details

• Total Peptide Content: 10mg per nasal spray unit

• Delivery Format: Metered nasal spray

• Peptide Concentration: 100mcg per spray

• Estimated Sprays per Unit: ~100 sprays (device-dependent)

• Form: Aqueous peptide solution

• Packaging: Secure, sealed, tamper-evident nasal spray bottle

• Source: High-quality lab-grade peptide, independently third-party tested

• Purity: ≥98% (peptide content verified prior to formulation)

• Note: Intended strictly for controlled laboratory and experimental research applications

Overview of PT-141 Nasal Spray’s Research Profile

PT-141, also known as Bremelanotide, is a synthetic peptide analog of α-melanocyte-stimulating hormone (α-MSH) developed specifically for its selective interaction with melanocortin receptors, particularly MC3R and MC4R. In a nasal spray formulation, PT-141 is studied for its role in central melanocortin signaling, neuroendocrine pathway regulation, and intranasal peptide delivery mechanisms.

Unlike melanocortin peptides primarily studied for pigmentation signaling, PT-141 is examined for its targeted activity within central neural pathways. The intranasal format enables researchers to explore non-invasive peptide transport routes and evaluate peptide access to central signaling systems in controlled experimental models.

Research Specifics

PT-141 nasal spray has been investigated in non-clinical research for its involvement in:

• Melanocortin Receptor Pathway Analysis
  Studies examining selective activation of MC3R and MC4R and downstream intracellular signaling cascades.

• Neuroendocrine Signaling Research
  Exploration of peptide-mediated communication within central nervous system regulatory networks.

• Central Peptide Transport Models
  Investigation of intranasal delivery as a route for peptide access to neural signaling regions.

• Receptor Selectivity Studies
  Comparative analysis of PT-141 versus other melanocortin peptides such as MT-2.

• Peptide Stability & Delivery Research
  Assessment of aqueous peptide formulation stability and metered spray consistency.

Key Features

• Peptide Class: Melanocortin receptor agonist (α-MSH analog)

• Primary Receptor Targets: MC3R and MC4R

• Molecular Weight: ~1025 Da

• Delivery Method: Metered intranasal spray

• Per-Spray Output: 100mcg PT-141

• Total Content: 10mg per unit

• Purity: ≥98% research-grade peptide

• Laboratory Stability: Formulated for stability in aqueous solution under appropriate storage conditions

Potential Applications

Researchers may explore PT-141 nasal spray in studies involving:

• Central melanocortin receptor signaling

• Neuroendocrine pathway modeling

• Melanocortin receptor selectivity research

• Intranasal peptide delivery system evaluation

• Comparative melanocortin peptide investigations

Specifications

This product is supplied as a sealed, tamper-evident nasal spray unit to preserve peptide integrity and dosing consistency. The metered spray mechanism ensures uniform peptide delivery per actuation. Store under recommended refrigerated conditions to maintain stability.